Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bovine Asporin (ASPN) ELISA Kit-Sandwich

Cat. No.EK11F778

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Bovine Asporin (ASPN) ELISA Kit-Sandwich is designed for the quantitative determination of Bovine Asporin (ASPN) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Bovine ASPN.
Target Species Bovine
Species Reactivity Bovine
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 270 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids.

Target Information

Bovine Asporin is encoded by the ASPN gene in cattle. ASPN, a member of the small leucine-rich proteoglycan (SLRP) family, is a secreted stroma protein that has been implicated in the development of various types of cancer. Asporin is involved in processes such as bone mineralization, biomineral tissue development, and negative regulation of transforming growth factor beta receptor signaling pathway.

Target/Biomarker Bovine ASPN
Target Synonym asporin
Gene ID 507990
UniProt ID Q3ZBN5

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Li, H. et al. Cytoplasmic Asporin promotes cell migration by regulating TGF-β/Smad2/3 pathway and indicates a poor prognosis in colorectal cancer. Cell death & disease. 2019, 10: 109.
Inquiry Basket